NAAA
HALO icon

New Age Alpha Advisors’s Halozyme HALO Stock Holding History

New Age Alpha Advisors’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.61M Sell
24,987
-535
-2% -$37.7K 0.08% 340
2025
Q4 		$1.72M Sell
25,522
-987
-4% -$66.4K 0.07% 338
2025
Q3 		$1.94M Sell
26,509
-756
-3% -$50.2K 0.08% 310
2025
Q2 		$1.42M Buy
27,265
+1,466
+6% +$83.4K 0.06% 372
2025
Q1 		$1.65M Sell
25,799
-2,465
-9% -$143K 0.07% 347
2024
Q4 		$1.35M Buy
+28,264
New +$1.45M 0.05% 392

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

New Age Alpha Advisors's HALO Position: Q1 2026 in Review

New Age Alpha Advisors reduced its Halozyme (HALO) stake by 2.1% in Q1 2026, selling an estimated $37.7K and leaving 24,987 shares worth $1.61M. The position accounts for 0.08% of the portfolio, ranked #340.

New Age Alpha Advisors first reported a position in HALO in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.94M in Q3 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • New Age Alpha Advisors held 24,987 shares of Halozyme worth $1.61M as of Q1 2026.
  • New Age Alpha Advisors sold 535 Halozyme shares in Q1 2026, an estimated $37.7K.
  • Halozyme made up 0.08% of New Age Alpha Advisors's portfolio in Q1 2026, its #340 holding.
  • New Age Alpha Advisors first reported a position in Halozyme in Q4 2024 and has held it in 6 quarters since.
  • New Age Alpha Advisors's Halozyme position peaked at $1.94M in Q3 2025.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on New Age Alpha Advisors's 13F filing for Q1 2026, filed 11 May 2026.